Clinical Trial of Mexiletine Hydrochloride for Spinal and Bulbar Muscular Atrophy
Clinical Trial of Mexiletine Hydrochloride for Spinal and Bulbar Muscular Atrophy
Recruiting · NCT06862596 · Registry updated 2025-04-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Trial of Mexiletine Hydrochloride for Spinal and Bulbar Muscular Atrophy | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Kennedy disease, X-linked disease, central nervous system disorder, hereditary disease, inherited neurodegenerative disorder, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, spinal cord disorder, spinal muscular atrophy | Recruiting | Phase 2 / Phase 3 | 2025-04-16 | NCT06862596 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Masahisa Katsuno | 1 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chiba University Hospital | Chiba | Japan | 6 |
| Hokkaido University Hospital | Sapporo | Japan | 12 |
| Jichi Medical University Hospital | Shimotsuke | Japan | 5 |
| Osaka University Hospital | Suita | Japan | 1 |
| Tokyo University Hospital | Bunkyō City | Japan | 1 |